Preference in time of insulin injection in type 2 diabetic patients treated with once-daily long-acting insulin analog

Diabetes Obes Metab. 2016 Nov;18(11):1098-1099. doi: 10.1111/dom.12762.

Authors

M Takahara¹, T Shiraiwa², N Katakami³, T A Matsuoka³, I Shimomura³

Affiliations

¹ Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
² Shiraiwa Medical Clinic, Kashiwara City, Osaka, Japan.
³ Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.

PMID: 27502692
DOI: 10.1111/dom.12762

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy
Humans
Hypoglycemic Agents*
Insulin, Long-Acting / administration & dosage*
Time Factors

Substances

Hypoglycemic Agents
Insulin, Long-Acting